drugset / Trial / NCT01514110
Gastric Cancer RAD001 Study
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine dose limiting toxicities (DLT) and maximum tolerated dose (MTD) of RAD001, as well as to assess tumor response and overall survival.
Timeline
- Start
- 2008-01-23
- Primary completion
- 2019-03-06
- Completion
- 2019-03-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | — | — |